Back to Search Start Over

694P Full efficacy analysis of phase I/II trial investigating bexmarilimab, a novel macrophage-guided immunotherapy in refractory solid tumors.

Authors :
Bono, P.
Verlingue, L.
De Miguel Luken, M.J.
Pasanen, A.
Robbrecht, D.
Skyttä, T.
Iivanainen, S.M.E.
Shetty, S.
Ma, Y.T.
Graham, D.M.
Arora, S.P.
Jaakkola, P.M.
Yap, C.
Hollmén, M.
Koivunen, J.P.
Minchom, A.R.
Source :
Annals of Oncology. 2023 Supplement 2, Vol. 34, pS483-S484. 2p.
Publication Year :
2023

Subjects

Subjects :
*IMMUNOTHERAPY
*TUMORS

Details

Language :
English
ISSN :
09237534
Volume :
34
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
173098748
Full Text :
https://doi.org/10.1016/j.annonc.2023.09.1880
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details